Why the study?
Is the Urdu version of the Morisky Medication Adherence Scale (MMAS) a reliable and valid measure of medication adherence in hypertensive patients?
Is the Urdu version of the Morisky Medication Adherence Scale (MMAS) a reliable and valid measure of medication adherence in hypertensive patients?
The Urdu version of the MMAS is a reliable and valid tool for assessing medication adherence in hypertensive patients in Pakistan.
Answers are grounded in this paper and cite their sources.
May aid adherence screening in Urdu-speaking hypertensives; leaves open prospective outcome validation.
Objective: The study aims to translate and examine the psychometric properties of the Urdu version of Morisky Medication Adherence Scale (MMAS) among hypertensive patients in Quetta, Pakistan.Method: A standard ‘‘forward–backward’’ procedure of translation was used to translate the English version of MMAS into Urdu. The translated version was than validated on a convenience sample of 150 hypertensive patients attending a public hospital in Quetta, Pakistan, between July and September 2010. The reliability of the translated questionnaire was tested for internal consistency. Validity was confirmed using convergent and known group validity.Results: Adopting the recommended scoring method, the mean ± SD of MMAS scores was 6.23 ± 0.9. The instrument demonstrated good internal consistency (Cronbach’s a = 0.701). The test–retest reliability value was 0.8 (p < 0.001). A positive correlation between the 8 and 4 item MMAS was found (r = 0.765; p ≤ 0.01). There was a significant relationship between MMAS categories and the hypertension control groups (χ2 = 19.996; p < 0.001). The MMAS sensitivity and specificity, with positive and negative predictive values, were 46.15%, 60.00%, 45.0% and 61.11%, respectively.Conclusions: Results from this translation and validation study conclude that the Urdu version of the MMAS is a reliable and valid measure of medication adherence and therefore a valid tool for the advancement of person-centered healthcare.
No takes yet. Share an insight, caveat, or question.
Saleem et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: